Relatively slow hematopoietic recovery after isolated bone marrow (I-BM) engraftment is probably caused by a disrupted microenvironment of stromal and stem cells. Thus, we compared the kinetics of hematopoietic recovery of lethally irradiated rats that received I-BM versus vascularized BM (V-BM). Total body irradiated (TBI; 8 Gy) Lewis (LEW; RT1 l ) rats were either injected IV with syngeneic sex-mismatched 80 × 10 6 I-BM or transplanted with 80 × 10 6 V-BM in orthotopic hind limb grafts. Ten days later, peripheral blood (PB) and mesenteric lymph nodes (MLN) of these recipients were examined for the presence of donor-derived hematopoietic cells with a panel of monoclonal antibodies by FACS. To detect male cells in sex-mismatched female recipients, PCR was performed using male Y chromosome primers. When examined in PB and MLN, recipients transplanted with V-BM displayed significantly faster recovery of leukocytes (CD43 + ), monocytes (CD14 + ), and T cells (CD5 + ) in comparison with I-BM recipients. In addition, only V-BM (but not I-BM) groups contained stroma-like male-positive cells in PB and MLN. Our results suggest that V-BM transplants provided superior hematopoietic recovery in comparison to I-BM transplants. We postulated that close proximity between stromal and stem cells in V-BM is essential for efficient repopulation with progenitors of different lines of leukocytes.
INTRODUCTION
small number of donor stromal cells (6), I-BM transplants were enriched with additional number of donor stromal cells. Despite this increased number of stromal Graft failure after isolated bone marrow (I-BM) transplantation may be mortal for patients subjected to radio-cells, the hematopoietic recovery was at the same slow tempo as in recipients without extra stromal cells (1, 3) . therapy and/or chemotherapy. Even when successful, slow recovery of hematopoietic cells after I-BM trans-In contrast, vascularized BM (V-BM) in intact bone grafts efficiently recruited donor-derived stromal cells plantation contributes to a variety of complications including severe infections. Although the process of he-into the recipient's bone cavities (14, 15, 17) . Similarly, an orthotopic hind limb transplant model maintains in matopoiesis remains incompletely understood, it seems to require a delicate interaction between progenitors and V-BM the spatial relationship of stromal cells and stem cells (25) , thereby improving hematopoietic recovery in stromal cells within the microenvironment of extracellular matrix (8, 33, 40) . Because direct cell-to-cell contact the lethally irradiated syngeneic rats (18, 19, 26, 35) .
In the present study, we compared the tempo of he-and multiple hematopoietic growth factors are essential, transplantation of I-BM may dramatically limit hemato-matopoietic recovery after V-BM versus I-BM transplantation. Hematopoietic repopulation in the peripheral poietic recovery (10,21).
A routinely used clinical method of IV infusion of blood (PB) and mesenteric lymph nodes (MLN) was much faster after V-BM grafting with the appearance of I-BM provides hematopoietic cells that are severely deprived of cell-to-cell contact with stromal cells. The donor-derived stromal cells in recipient BM. Thus, close proximity of stromal cells and stem cells in V-BM trans-necessity for cell-to-cell contact was suggested by experimental work (1, 3, 6) . Because I-BM contains only a plants dramatically improved hematopoietic recovery.
MATERIALS AND METHODS
recognizing monocytes and macrophages (Serotec, Oxford, England). For cell labeling each mAb was used Animals at an optimal dilution based on the preliminary dose-Three-month-old male and female Lewis rats (LEW; response titration. The secondary rabbit anti-mouse IgG RT1 l ) were bred and maintained in our own pathogen-F(ab) 2 fragment conjugated with fluorescein isothiocyafree facility. All experiments performed were under apnate (FITC) was used in the second step labeling. Oneproval of the institutional Animal Welfare Committee.
color (green fluorescence at 535 mm) analysis was performed on FACS (Becton Dickinson, San Jose, CA). In Total Body Irradiation (TBI) addition, mouse isotypes IgG1 and IgG2 were used as Graft recipients were exposed to an 8 Gy gamma irracontrols. Data were analyzed using FLOWMATE softdiation from a 60 Co source (Theratron) at the dose of ware from DAKO (Glostrup, Denmark). The absolute 150 cGy/min. count for each cellular subset was calculated as the product of leukocyte count and the cellular subset per-V-BM in Hind Limb Transplantation centage. The donor hind limb was amputated at the groin level PCR Analysis of Hemopoietic Cells with femoral and iliac artery and the vein dissected above this level to obtain a long vascular stump for For PCR analysis BM, PB, and MLN were isolated anastomoses. Next, the hind limb of the recipient was on Lymphoprep (Nycomed, Oslo, Norway) using condiamputated at the midthigh level. End-to-end anastomotions of 1200 rpm for 45 min. ses of the artery and vein were made with the donor vessels using 10:0 monofilament sutures. The stumps of BM Stromal Cell Culture sciatic nerve were stitched. The femur was anastomosed The stromal cell layer was obtained using the prewith an intramedullary metallic stent. Muscles and skin viously described method (31) . Ten days after transplanwere then stitched. As estimated in five LEW rats (200tation, BM cells were flushed out from the recipient's 250 g), the total number of BM cells in each transplant tibia with RPMI-1640 containing 5% deactivated FCS was Ϸ80 × 10 6 BM cells, namely 27.0 ± 2.3 × 10 6 in half (Gibco BRL). Unfractionated BM cells were plated at of femur, 23.9 ± 2.7 × 10 6 in tibia, and 30.0 ± 7.0 × 10 6 the density of 10 6 cells/ml in selecting MEM medium foot bones.
(2% FCS, 12% horse serum, 100 µM/L 2-mercaptoethanol, 2 mM/L L-glutamine, 1 µM/L hydrocortisone, 100 Experimental Design U/ml penicillin, and 100 µg/ml streptomycin) and cul-Studies were carried out in four experimental groups: tured for 3 weeks (37°C; 5% CO 2 humidified atmo-1) irradiated female recipients received 80 × 10 6 male Vsphere). Medium was changed twice a week. BM in hind limb transplant (n = 9); 2) irradiated female recipients received IV infusion of 80 × 10 6 male I-BM PCR Method to Detect Male Y Chromosome cells (n = 7); 3) irradiated male recipients received 80 × To identify Y chromosome (36) , DNA samples ob-10 6 male V-BM in hind limb transplant (n = 6); 4) irraditained from rats were evaluated by PCR with specific Y ated male recipients received IV infusion of 80 × 10 6 fechromosome primers. Genomic DNA was isolated from male I-BM cells (n = 8). In addition, normal nonirradi-BM, PB, MLN, and BM stromal cells using DNAzol ated male and female rats served as controls (n = 12). method (Gibco BRL, Inchinnan, Scotland). Quantification of DNA was performed on a Gene Quant spectro-Cell Collection photometer. PCR reaction mixture contained 5 µg of Ten days after I-BM or V-BM transplantation, recipi-DNA, 1.5 U Taq DNA polymerase (PCR Beads, Pharents were sacrificed and BM from recipient tibia, periphmacia Biotech, Upssala, Sweden), and 25 pmol of rat Y eral blood (PB), and mesenteric lymph nodes (MLN) chromosome primers (sense, 5′-GAG AGA GGC ACA were harvested.
AGT TGGC-3′; antisense, 5′-AAT ACC AGT GGA TGT GAT GCGG-3′); PCR amplification was carried out in Flow Cytometry Analysis a Thermal Cycler (MJ Research, Weltham, MA, USA). The PCR products were analyzed by electrophoresis in Single-cell suspensions of PB and MLN were analyzed using: mouse anti-rat CD43 (W3/13) monoclonal 12.5% polyacrylamide gel (Phast System, Pharmacia Biotech. Upssala, Sweden), followed by silver staining. antibody (mAb) directed to leukocytes; anti-rat CD15 (HIS48) mAb recognizing granulocytes; anti-rat CD5
The gels were scanned and analyzed by ONE-DSCAN software (Scanalytics Inc, England). (OX19) recognizing T cells; and anti-rat CD14 (ED1)
Statistics
Results are presented as mean ± SD. For statistical analysis Student's t-test was used. Differences in data were considered significant when p < 0.05.
RESULTS

Hematopoietic Recovery of PB Leukocytes Following V-BM Versus I-BM Transplantation
Irradiated female recipients were injected IV with 80 × 10 6 male I-BM cells or were transplanted with 80 × 10 6 V-BM cells in a hind leg transplant. Ten days later the total number of PB leukocytes was counted in each experimental group as well as in normal control rats ( Table 1 ). In addition, numbers of CD43 + leuko- of I-BM transplants (4.4 ± 9.4 × 10 2 /µl). FACS analysis revealed five-to sixfold higher numbers of leukocytes, granulocytes, and T cells in the V-BM group compared with the I-BM group (Table 1) . Interestingly, although V-BM transplants are a much better source of progeni-PB contained a similar percentage of CD43 + leukocytes tors for hematopoietic recovery in comparison with in V-BM grafted rats (80.8 ± 6.2%) and normal rats I-BM transplants. (83.7 ± 4.4%), significantly less CD43 + leukocytes were Hematopoietic Recovery in MLN Following found in I-BM (62.8 ± 8.3%; p = 0.01) ( Fig. 1 ). In con-V-BM Versus I-BM Transplantation trast, PB revealed a significantly lower percentage of CD15 + granulocytes in V-BM (32.2 ± 12.2%) and nor-Almost identical patterns of hematopoietic recovery observed in PB were seen in MLN ( Table 2 ). Within 10 mal (17.70 ± 4.03%) groups than in the I-BM group (65.5 ± 9.3%; both p = 0.01). Although the percentage days after transplantation, MLN showed a 20-fold higher number of leukocytes in V-BM (20.8 ± 10.2 × of CD5 + T cells in PB was similar in V-BM recipients (70.7 ± 2.8%) and in normal rats (63.0 ± 5.9%), both 10 7 /g) than in I-BM (0.9 ± 0.3 × 10 7 /g) transplanted recipients. When compared with normal rats (96.0 ± 6.5 × groups were much higher than in I-BM recipients (41.7 ± 14.8%; p = 0.01). However, no difference was 10 7 /g), MLN were replenished with leukocytes by almost 20% in the V-BM group whereas only by 1% in observed in the percentage of CD14 + monocytes among all three groups. In conclusion, these results suggest that I-BM group. Although the composition of CD43 + leuko- cytes in MLN was similar in the V-BM (69.9 ± 4.2%) NS); both values were significantly lower than in the I-BM transplant group (6.4 ± 0.8%; p < 0.02) (Fig. 2 ). and normal (73.4 ± 3.5%; NS) groups, both these values were significantly higher than in the I-BM group Based on the absolute numbers of leukocytes presented in Table 2 , these results document that rate of recovery (57.4 ± 2.8%; both p < 0.04) (Fig. 2) . As previously noticed in PB, there was more CD15 + granulocytes after in MLN is dramatically improved after V-BM transplantation. V-BM grafting (3.2 ± 0.5%) and I-BM grafting (4.0 ± 2.4%) in comparison to normal rats (0.6 ± 0.1%; both p < 0.01). Although in comparison to normal (78.4 ± Determination of Donor Hematopoietic Cells 7.9%; p < 0.01), the percentage of CD5 + T cells in MLN by PCR Analysis was lower in the V-BM group (62.5 ± 9.9%; p < 0.01),
To demonstrate that donor BM cells were repopulatit was significantly higher than in the I-BM group ing the TBI-treated recipients, we transplanted BM from (46.4 ± 9%; p = 0.01). Similar low levels of CD14 + male donors to female recipients or vice versa (Fig. 3 ). monocytes in MLN were observed in the V-BM trans-Using a PCR method and primers specific to recently plant group (1.7 ± 0.5%) and in normal rats (1.0 ± 0.4%;
identified sex-determining gene Y (Y-Sry) (16), we identified the origin of sex-mismatched BM-derived hematopoietic cells in BM, PB, and MLN. Within 10 days after transplantation of male V-BM or male I-BM to female recipient, single-cell suspension prepared from BM, PB, and MLN was purified on Lymphoprep to enrich for lymphocytes, followed by extraction of DNA (Fig. 3A) . plantation. 
Measurement of Donor and Recipient thereby improve the hematopoietic recovery after transplantation. BM Stromal Cells by PCR Analysis
To examine the presence of donor origin stromal DISCUSSION cells after either V-BM or I-BM transplantation, recipient tibia BM cells (obtained 10 days after grafting) were
The present results document that transplantation of V-BM dramatically accelerates the process of hemato-cultured for 3 weeks under conditions promoting growth of stromal cells (31) . At the end of culture, DNA ex-poietic regeneration in lethally irradiated recipients in comparison with transplantation of I-BM. Only 10 days tracted from adherent BM stromal cells was examined for the content of Y-Sry DNA (Fig. 4) . Although cul-after V-BM grafting, the number of leukocytes present in BM of recipient tibia was threefold higher than after tured stromal cells from female recipients of male V-BM transplants displayed significant amounts of Y-Sry I-BM transplantation. Similarly, the number of leukocytes was fivefold higher in PB and 10-fold higher in MLN DNA, those from recipients of I-BM transplants had no detectable donor Y-Sry DNA. As expected, stromal cells after V-BM than after I-BM transplantation. Moreover, after I-BM transplantation PB contained predominantly from male recipients of either female V-BM or female I-BM had similar levels of Y-Sry DNA. These results granulocytes and only a small number of T lymphocytes. In contrast, 10 days after V-BM transplantation the num-strongly suggest that V-BM transplants are a much better source of stromal cells than I-BM transplants and ber of T lymphocytes was sixfold higher in PB than after I-BM transplantation. Because deficiency of T lympho-thermore, stromal cells release multiple hematopoietic cytokines and extracellular matrix proteins into the mi-cytes has always been considered a major impediment of clinical I-BM transplantation (11,27-29,34), our results croenvironment (7,30). The necessity for interaction between stromal and stem cells has been well documented suggest that V-BM may offer a significant advantage. Although clinical transplantation of bone with V-BM (4, 24, 37) . As shown herein, accelerated proliferation of donor cells after V-BM transplantation was confirmed may not be feasible, enriched I-BM with extra stromal cells or treatment with factors promoting growth of stro-by the higher quantity of donor Y-Sry DNA observed in BM, PB, and MLN in recipients of V-BM than of I-BM mal cells may improve I-BM engraftment. Cultures from recipients transplanted with I-BM of HLA-identical but transplants. Considering the fact that V-BM cells remain intact in the bone and infused I-BM cells have disturbed sex-different siblings showed that stromal cells became progressively donor in origin (22) . We propose that he-cell-to-cell contact, we postulate that the presence of donor Y-Sry DNA in V-BM recipients documents very ef-matopoietic recovery may be accelerated by addition of donor stromal cells from blood or BM expanded in vitro ficient "physiological" BM repopulation. Thus, vascularized intact BM provides a much better source of stem/ to I-BM transplants; under some culture conditions stromal cells demonstrate high capacity for self-replication stroma cells for hematopoietic recovery. Transplantation of bone along with BM cells facili-(9,23). Furthermore, I-BM transplants may be coinfused with stromal cells bioengineered to secrete growth fac-tated the host reconstitution with hematopoietic cells of donor origin. Donor-derived bones implanted under the tors, such as IL-3 and IL-6 (20) or recently identified factors by differential screening (42) to improve I-BM kidney capsule along with I-BM enhanced implantation of the donor-derived hematopoietic progenitors (17) . engraftment.
Graft failure and delayed engraftment of hematopoi-Coimplantation of bone fragments and I-BM from an adult human into SCID mice improved long-term hema-etic cells proved to be the major complications with complete recovery of lymphoid cells often requiring as topoiesis (14). For similar reasons, a model of V-BM in hind limb accelerated the recovery of TBI-treated recipi-long as 1 year or more following clinical I-BM transplantation. Although little is known about the mechanisms ents. Intact BM stromal cells produce a number of different cytokines that are important in hematopoiesis: regulating hematopoietic reconstitution, association between BM progenitor cells and their microenvironment granulocyte-macrophage colony stimulating factor (GM-CSF), M-CSF, G-CSF, interleukin (IL)-1β, IL-7, stem is essential in the development and maintenance of a functional hematopoietic system. Successful BM en-cell factor (SCF), transforming growth factor (TGF)-β1, tumor necrosis factor (TNF)-α, and hematopoietic growth graftment depends on several factors, including sufficient number of stem cells that express homing receptors factor (HGF) (38) . In addition, some reports demonstrated that osteoblasts are necessary for maintenance of for their adhesion in the BM compartment (32,39). Fur- 
